Medication info
TwinTel Tablet 40/10mg

TwinTel Tablet 40/10mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletTelmisartan›40mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Gujoo Pharmaceutical Co., Ltd.
Appearance
<For domestic use> This is a white and light gray, double-layered oval tablet with a convex shape. <For export> Rectangular tablets that are white or whitish.
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201706198 · Approved 2017.07.26 · Insurance code 669804910

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine at 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
◦ Children: The use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Gujoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication assists patients with essential hypertension in controlling their blood pressure more effectively when treatment with amlodipine or telmisartan alone is insufficient. This helps to lower the risk of cardiovascular complications due to elevated blood pressure. It is used to improve blood pressure control in essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine at 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

◦ Children: The use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, especially during the second and third trimesters, as it can pose a serious risk to the fetus. Patients with allergies to any of the components in this medication or with certain heart diseases, liver impairment, severe hypotension, etc., should not take this medication. Caution is needed for patients with compromised liver or kidney function, older adults, and patients with certain heart diseases when using this medication. During treatment, side effects such as dizziness or edema may occur, and if symptoms are severe, medical consultation is advised. When taking this medication with other drugs, interactions may occur; therefore, it is essential to inform your healthcare provider about any other medications currently being taken. Women who are pregnant or breastfeeding should not take this medication, and if pregnancy is confirmed, it should be discontinued immediately. Safety and efficacy in pediatric patients have not been sufficiently established, so usage is not recommended. Overdosage can lead to severe hypotension or cardiac issues, so dosage should be adhered to closely, and immediate medical attention should be sought in case of overdose. Store this medication out of reach of children, maintaining the original packaging during storage. It is advisable to take the medication directly from the sealed package.

Side effects

  • Dizziness
  • peripheral edema
  • fainting
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 99 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylaxis
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • hypesthesia
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • muscle rigidity
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gum hypertrophy
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver dysfunction
  • liver disease
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • hyperhidrosis
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased serum creatinine
  • weight gain
  • weight loss
  • increased serum uric acid
  • increased creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a light-protected container. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

<For domestic use> This is a white and light gray, double-layered oval tablet with a convex shape. <For export> Rectangular tablets that are white or whitish.

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.